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Limited information is available on antimicrobial susceptibility and clonal distribution of 
Staphylococcus aureus in the Caribbean region. The aims of this study were to determine 
the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the 
frequency and population structure of methicillin-resistant S. aureus (MRSA) in St. Kitts 
and Nevis, a small island country in the West Indies. A total of 152 S. aureus isolates were 
collected from consecutive samples submitted to the clinical microbiology laboratory of 
the main referral hospital from March 2017 to January 2018. Samples came from all units 
in the hospital and a small number came from external submissions, and comprised a 
total of 119 clinical specimens and 33 nasal swabs collected from staff and patients. All 
S. aureus isolates were confirmed by matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry. Minimal Inhibitory Concentrations (MICs) of clinically relevant 
antimicrobials were determined by broth microdilution, and diversity of MRSA isolates 
was assessed by whole genome sequencing (WGS) analysis. MRSA accounted for 45% 
(69/152) of the isolates. The highest rates of resistance to non-β-lactam agents were 
observed for erythromycin (55%), moxifloxacin (41%), and levofloxacin (40%), whereas 
resistance to the other drugs tested was ≤6%. All isolates were susceptible to ceftaroline, 
linezolid, teicoplanin, telavancin, and vancomycin. WGS-based multilocus sequence typing 
(MLST) showed that approximately 88% of the MRSA isolates belonged to ST8. 
Phylogenetic analysis on 801 single-nucleotide polymorphisms (SNPs) identified among 
the MRSA ST8 isolates indicates a large degree of genetic diversity. However, all ST8 
strains clustered within the distinct clade that defines the USA300 North American 
Epidemic lineage (Panton-Valentine Leukocidin (PVL) +, arginine catabolic mobile element 
(ACME) +, Staphylococcal cassettes chromosome mec IVa (SCCmec IVa)). Our data show 
high levels of methicillin, macrolide, and fluoroquinolone resistance among S. aureus on 
St. Kitts and Nevis. The USA300 North American epidemic lineage is responsible for the 
vast majority of MRSA infections on this Caribbean island.
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INTRODUCTION
Staphylococcus aureus is an opportunistic pathogen that causes 
a variety of infections ranging from mild skin and soft tissue 
infections to severe bacteremia and pneumonia. Antimicrobial 
resistance is a great concern in this species because of the 
global spread of methicillin-resistant Staphylococcus aureus 
(MRSA) that are resistant to all conventional β-lactams and 
may display additional resistance to non-β-lactams. A few 
pandemic MRSA clones are distributed worldwide, whereas 
others predominate in restricted geographical areas (Monecke 
et  al., 2011). Molecular epidemiological studies aimed at 
understanding local patterns of antimicrobial resistance, MRSA 
prevalence, and clonal distribution are essential to implement 
measures for control and treatment of S. aureus infections.
There is limited information on antimicrobial susceptibility 
and genetic diversity of S. aureus in the Caribbean, a major 
destination of international tourism. The current knowledge 
is limited to studies from Trinidad and Tobago (Akpaka et al., 2006, 
2007, 2011; Orrett and Land, 2006; Monecke et  al., 2014) and 
sporadic reports from Cuba (Hopman et  al., 2012), Dominican 
Republic and Martinique (Uhlemann et al., 2012), Jamaica (Brown, 
2015), and Puerto Rico (Rodríguez et al., 2002; Morales-Torres 
et  al., 2015). It has been shown that the majority of strains 
from this region belong to Clonal Complex (CC) 8 (Akpaka 
et  al., 2017; Strauß et  al., 2017).
The aims of this study were to determine the prevalence 
of antimicrobial resistance among S. aureus isolates and to 
reveal the frequency and population structure of MRSA in 
St. Kitts and Nevis, a small island country in the West Indies.
MATERIALS AND METHODS
Ethics
The Interim Ethics Review Committee (IERC) of the Federation 
of Saint Christopher and Nevis has reviewed the protocol and 
based on the findings approved the research project. The IERC 
approval code is 2017-11-007.
Bacterial Isolates
S. aureus isolates were obtained from consecutive samples submitted 
between March 2017 and January 2018, to the clinical microbiology 
laboratory at Joseph N France General Hospital, St. Kitts. The 
samples from which S. aureus was isolated included 119 clinical 
specimens and 33 nasal swabs from hospital staff (n  =  29) 
and patients (n  =  4). S. aureus was presumptively identified by 
colony morphology, catalase and coagulase test at the hospital 
laboratory, and later confirmed at the University of Copenhagen 
by matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS, Vitek MS RUO, bioMérieux, 
France) using Saramis v.3.5 (bioMérieux) for spectral interpretation. 
Antimicrobial susceptibility was tested by broth microdilution 
using the EUSTAPF commercial panel (Thermo Fisher Scientific, 
Denmark) according to the methodology and breakpoints specified 
by the European Committee on Antimicrobial Susceptibility 
testing (EUCAST1). Clinical breakpoints were available for all 
drugs, except mupirocin for which we  used the epidemiological 
cutoff. Isolates falling in the intermediate category were considered 
as resistant when reporting data on prevalence of resistance. 
Methicillin resistance was assessed using a multiplex PCR as 
described by Stegger et  al. (2012).
Whole Genome Sequencing and Analysis 
of Methicillin-Resistant S. aureus Isolates
Overnight cultures were grown in tryptic soy broth at 37°C 
with 200-rpm shaking. Genomic DNA from the MRSA strains 
was extracted using the DNeasy Blood and Tissue kit (Qiagen). 
Library preparation was carried out using the Nextera XT kit 
and paired end 2 × 250 bp sequencing on a MiSeq, all following 
standard Illumina protocols (Illumina, Inc., United States). All 
raw reads have been deposited in the European Nucleotide 
Archive under study accession number PRJEB29509.
Initial analyses (de novo assembly and multilocus sequence 
type (MLST) determination) were performed in CLC Genomics 
Workbench v.11.0 using the tools within the Microbial Genomics 
Module. The ResFinder v.3.0, VirulenceFinder v.1.5, and 
SCCmecFinder v1.2 Web-based pipelines at the Centre for 
Genomic Epidemiology 2 were used to search for the presence 
of known virulence and antibiotic resistance genes, and to 
determine the Staphylococcal Cassette Chromosome mec 
(SCCmec) types (Zankari et  al., 2012; Joensen et  al., 2014; 
Kaya et  al., 2018). To investigate the genetic relatedness of 
the St. Kitts and Nevis ST8 isolates, a rooted maximum 
likelihood tree was generated from core genome SNPs, 
performed as previously described by Strauß et  al. (2017). 
Briefly, sequence reads were mapped against the reference 
chromosome of S. aureus TCH1516, a USA300 ST8 strain 
(GenBank accession no. CP000730), using NASP v.1.0.0 
(Highlander et  al., 2007). First, duplicated regions in the 
reference were removed using NUCmer followed by aligning 
of the reads using the Burrows–Wheeler Aligner (Li and 
Durbin, 2009). All positions with <10-fold coverage or if the 
variant was present in <90% of the base calls were excluded. 
Indications of putative horizontal gene transfer events were 
purged from the alignment using Gubbins v.2.3 (Croucher 
et  al., 2014). The relatedness of the isolates was inferred 
using PHyML v.3.0 (Guindon et  al., 2010) with Smart Model 
Selection (Lefort et al., 2017) under the Bayesian Information 
Criterion with 100 bootstrap replicates. Additionally, a second 
rooted phylogeny of the St. Kitts ST8 strains against a global 
ST8 strain collection (Strauß et  al., 2017) was constructed 
similarly as described above.
RESULTS
A total of 152 S. aureus were isolated at the clinical microbiology 
laboratory of Joseph N France General Hospital between 
1 www.eucast.org
2 http://www.genomicepidemiology.org/
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March 2017 and January 2018. The most common source of 
isolation was pus (n  =  53), followed by nasal cavity (n  =  33), 
wounds (n  =  25), catheters (n  =  11), blood (n  =  7), skin 
(n  =  4), urine (n  =  3), and others (n  =  16). Thirty-three nasal 
isolates were obtained from screening hospital (n = 29) personnel 
and patients (n  =  4), and only one strain per individual was 
included. The isolates originated from the surgical ward (n = 30), 
accident and emergency (n = 8), hemodialysis (n = 17), nursery 
(n = 4), pediatric (n = 14), intensive care unit (n = 3), operation 
theatre (n = 1), medical ward (n = 9), and orthopedics (n = 36). 
There were 25 isolates from patients in the doctors’ office 
consultation rooms and 5 isolates from patients in private 
practice rooms at the hospital (Tables 1 and 2).
Seventy (46%) isolates were resistant to cefoxitin and 69 
of them (45%) were confirmed to be MRSA by mecA detection. 
MRSA was isolated from pus (n  =  35), nasal cavity (n  =  9), 
wounds (n  =  12), catheters (n  =  1), blood (n  =  3), skin 
(n  =  3), urine (n  =  2), or other/unknown samples (n  =  4) 
(Table 2). MRSA-positive samples originated from the following 
wards: surgical ward (n = 19), accident and emergency (n = 3), 
hemodialysis (n  =  1), nursery (n  =  3), pediatric, (n  =  8), 
intensive care unit (n  =  3), operation theatre (n  =  1), medical 
(n  =  3), and orthopedics (n  =  1). There were 14 MRSA 
isolates from doctors’ office consultation rooms and 5 MRSA 
isolates came from private practice rooms. The consultation 
rooms (doctors’ and private) can be  considered as outpatient 
samples. However, we  cannot exclude outpatients in other 
wards (e.g., the hemodialysis unit) (Table 1). The prevalence 
of resistance to non-β-lactam agents was high for daptomycin 
(130/152, 86%) erythromycin (81/152, 53%), moxifloxacin 
(58/152, 38%), and levofloxacin (58/152, 38%). Lower 
proportions of resistant isolates were seen for tetracycline 
(7/152, 5%), tobramycin (7/152, 5%), clindamycin (5/152, 3%), 
fusidic acid (5/152, 3%), gentamicin (3, /152, 2%), mupirocin 
(2/152, 1%), and trimethoprim/sulfamethoxazole (2/152, 1%). 
A single isolate was resistant to rifampicin. All isolates were 
susceptible to ceftaroline, linezolid, teicoplanin, telavancin, and 
vancomycin (Table 3).
In silico MLST based on WGS analysis of the 69 confirmed 
MRSA isolates showed a high prevalence of ST8 (61/69, 
88%). The remaining isolates belonged to ST5 (n  =  2), 
ST4080 (n  =  2), ST30 (n  =  1), ST72 (n  =  1), ST121 (n  =  1), 
and ST134 (n = 1). SNP-based analysis on the 61 ST8 isolates 
showed that these isolates differed in 801 core genome 
SNPs, indicating a high genetic diversity, with the majority 
of strains resolving into three clusters (Figure 1). In seven 
instances, identical or closely related (2–6 SNP differences) 
strains were observed. In two cases, two different patients 
in the same ward and month were infected with the 
same strain (S40/S41 and S135/S140). In three cases, two 
patients from different wards (S43/S127; S38/S68; S131/S133) 
and in one other case four (S62/S103/S128/S146) patients 
from different wards and eventually different times harbored 
either identical or closely related isolates (up to four SNP 
differences). The remaining cluster consisted of 12 skin or 
mucosa-associated strains, isolated from 7 wards and mainly 
between May and July from both inpatients and outpatients 
(Figure  1). Most of the MRSA isolates from nasal swabs 
(n  =  9) originated from hospital personnel (n  =  8) and 
included six ST8, one ST212, and one ST834 strains. The 
remaining nasal strain was isolated from a patient in ICU 
TABLE 1 | Origin of the samples from which total S. aureus and MRSA  
were isolated.
Origin Total S. aureus MRSA
Surgical ward 30 19
Orthopedics 36 10
Accident and emergency 8 3
Doctors office consultation rooms 25 14
Hemodialysis 17 2
Nursery 4 3
Pediatric 14 8
Intensive care unit 3 2
Private practices in clinic 5 5
Operation theatre 1 1
Medical 9 3
Total 152 69
TABLE 2 | Numbers of S. aureus and MRSA isolated from each sample type.
Sample type S. aureus MRSA
Blood 7 3
Catheter 11 0
Nasal 33 9
Pus 53 35
Wound 25 12
Skin 4 3
Urine 3 2
Other/unknown 16 5
Total 152 69
TABLE 3 | Percentages of antimicrobial resistance in methicillin-susceptible 
(MSSA) and methicillin-resistant S. aureus (MRSA).
Antimicrobial Resistance %
All S. aureus 
(n = 152)
MSSA  
(n = 82)
MRSA  
(n = 69)
Cefoxitin 46.0 1.2 100
Ceftaroline 0 0 0
Clindamycin 3.3 3.6 2.9
Daptomycin 85.5 75.9 97.1
Erythromycin 53.3 21.7 91.3
Fusidic acid 3.3 2.4 4.3
Gentamicin 2 0 4.3
Levofloxacin 38.2 7.2 75.4
Linezolid 0 0 0
Moxifloxacin 38.2 8.4 73.9
Rifampicin 0.7 0 1.4
Teicoplanin 0 0 0
Telavancin 0 0 0
Tetracycline 4.6 0 10.1
Tobramycin 4.6 0 10.1
Trimethoprim/
sulfamethoxazole
1.3 2.4 0
Vancomycin 0 0 0
Mupirocin 1.3 0 2.9
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and belonged to ST8. The ST8 isolates were scattered across 
the phylogeny without any apparent epidemiological 
relationship except one strain from a nurse, which was also 
found in a blood culture from an ICU patient indicating 
a possible link. However, the patient strain was isolated 
1  month before the nurse strain.
Nearly all isolates carried genes encoding resistance to 
streptomycin [ant(6)-Ia], amikacin and other aminoglycosides 
[aph(3')-III], fosfomycin (fosD), macrolides, lincosamides and 
streptogramins [mph(C) and mrs(A)], and penicillin (blaZ). 
Genes encoding resistance to trimethoprim (dfrG) and phenicols 
(cat) were found in four and one isolate, respectively. A second 
set core genome SNP phylogenies based on 8,859 variable 
positions was performed containing the St. Kitts and Nevis 
ST8 isolates and a global, representative collection of 224 
ST8s (Strauß et  al., 2017) to determine the origins of our 
strains (Figure 2A). All our ST8 isolates clustered exclusively 
within the USA300-NAE lineage (1,995 SNPs, Figure 2B), 
FIGURE 1 | Midpoint-rooted core genome phylogeny of the 61 St. Kitts and Nevis ST8 MRSA isolates using the chromosome of methicillin-resistant S. aureus 
TCH1516, a USA300 reference strain. Phylogeny was based on an alignment of 801 SNPs. Metadata describing sample month and origins is provided.
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with the majority of the isolates (85%) found within three 
St. Kitts and Nevis-specific clusters.
DISCUSSION
This is the first study providing insights into antimicrobial 
resistance and clonal distribution of S. aureus in St. Kitts and 
Nevis, and one of the few studies using WGS to understand 
the population structure within the Caribbean region. A high 
proportion of clinical isolates from this Caribbean island were 
resistant to methicillin, macrolides, and fluoroquinolones, 
mainly due to the widespread occurrence of USA300-NAE. 
This epidemic clone has been recently reported as the most 
frequent in other Caribbean countries, namely Cuba (Hopman 
et al., 2012), Martinique (Uhlemann et al., 2012), and Trinidad 
and Tobago (Monecke et al., 2014). Notably, we did not detect 
ST239-MRSA-III that was virtually the only MRSA clone 
circulating in Trinidad and Tobago until 2004 (Akpaka et  al., 
2007) and is still the most prevalent MRSA type in this 
country according to a recent study (Monecke et  al., 2014). 
Similarly, we isolated a single strain belonging to ST30-MRSA-V, 
another PVL-positive clone that was recently reported as 
predominant in the Dominican Republic and rare in Martinique 
(Uhlemann et  al., 2012). The latter clone was undetected in 
Trinidad and Tobago (Monecke et  al., 2014). Altogether, these 
data indicate the occurrence of geographical differences in 
the prevalence of MRSA clones within the Caribbean region.
The frequency of MRSA among S. aureus isolated at the main 
referral hospital in St. Kitts and Nevis was much higher than 
the MRSA isolation frequencies reported in other Caribbean 
countries (12–39%) (Akpaka et  al., 2006; Orrett and Land, 2006; 
Uhlemann et  al., 2012; Monecke et  al., 2014). However, these 
studies are not easily comparable since they were conducted in 
different years and used different methods for sample selection 
and strain isolation. Similar to isolates from Trinidad and Tobago 
(Akpaka et  al., 2006; Orrett and Land, 2006) and Martinique 
(Uhlemann et  al., 2012), MRSA isolates from 
St. Kitts and Nevis displayed high (≥40%) percentages of resistance 
to macrolides and fluoroquinolones. However, they were usually 
susceptible to older drugs such as tetracyclines, gentamicin, and 
potentiated sulfonamides as well as topical antimicrobials such 
as fusidic acid and mupirocin, which can be  usefully employed 
for managing skin and wound infections. We  observed one 
cefoxitin-resistant strain (MIC >8  μg/mL) that was mecA- and 
mecC-negative upon PCR testing. This phenomenon has previously 
been described and β-lactam resistance was attributed to mutations 
in various genes including those encoding penicillin-binding 
proteins (Banerjee et  al., 2010; Ba et  al., 2014). This strain needs 
further investigation to confirm the mechanism of resistance. 
Surprisingly we  had a very high prevalence of resistance against 
daptomycin. Most strains had an MIC of 2  μg/ml, which is just 
above the EUCAST breakpoint (Humphries et  al., 2013). There 
is no clear explanation for this high level of resistance and this 
needs further investigation.
None of the MRSA isolates from St. Kitts belonged to 
livestock-associated MRSA lineages. Recently, the occurrence 
of MRSA was reported in pigs in Trinidad (Gordon et  al., 
2014) and the livestock-associated clone ST398 has been 
associated with human infections in the Dominican Republic 
and Martinique (Uhlemann et  al., 2012). The apparent lack 
of this and other livestock-associated MRSA clones among 
human clinical isolates in St. Kitts and Nevis may reflect the 
limited size of livestock production in this country, which 
largely depends on import of meat and other food 
animal products.
A B
FIGURE 2 | Rooted phylogenies of (A) S. aureus ST8 isolates from St. Kitts and Nevis and from a global, representative collection (n = 224) described by  
Strauß et al. (2017), and (B) a detailed presentation of the 135 isolates belonging to the USA300-NAE lineage. Colored circles depict geographic region of origin. 
The scale bar indicates the substitution rate.
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The genome analyses revealed that all the ST8 isolates 
belonged to the USA300-NAE lineage. Within this lineage, 
the majority (85%) of the isolates fell into three specific 
clusters comprising only isolates from St. Kitts and Nevis. 
Overlaying information of geographical origin of all 
USA300-NAE isolates did not indicate any common source 
of the USA300-NAE, mainly because of the radial topology 
observed within this clade. This Caribbean island is a tourist 
hub receiving many cruise ships with passengers visiting the 
island for a day but with longer stay-tourism increasing. 
Moreover, there is a large influx of students and residents 
from the US, and the local population has many contacts 
with the US as many have family members living there. This 
close contact may explain the diversity seen within ST8 as 
new strains may have been introduced on multiple occasions, 
and then evolved into three distinct island-specific 
USA300-NAE sub-lineages.
We observed identical strains in patients from the same 
ward during the same month as well as in patients in different 
wards at different times. One cluster of 12 strains that were 
very similar was detected over a 3-month period during the 
hot season, and spanned seven different wards. It is unclear 
if this was an outbreak.
The major limitation of this study is that it is based on 
passive surveillance. The actual community prevalence of 
MRSA in the population of St. Kitts and Nevis is unknown. 
Furthermore, our study population could be  subjected to 
sampling bias since patients were not routinely sampled for 
microbiological analysis. All samples were obtained from the 
island’s main hospital, which acts as a referral laboratory for 
the other hospitals in the country. This could lead to an 
overestimation of MRSA among S. aureus isolates.
In conclusion, almost half of the S. aureus infections recorded 
at the Joseph N France General Hospital in St. Kitts and Nevis 
are caused by MRSA. Most of the MRSA strains (88%) belong 
to the multidrug-resistant USA300-NAE lineage, with the 
presence of three major country-specific sub-lineages circulating 
in this Caribbean island country.
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